# Comparison of 2 NovoFine® Needles on the Reflux of Insulin

> **NCT00872560** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 60 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Delivery Systems

## Interventions

- **DEVICE:** NovoFine® needle 6 mm
- **DEVICE:** NovoFine® needle 8 mm

## Key facts

- **NCT ID:** NCT00872560
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01-20
- **Primary completion:** 1998-07-27
- **Final completion:** 1998-07-27
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00872560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00872560, "Comparison of 2 NovoFine® Needles on the Reflux of Insulin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00872560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*